Cello Health Acquires ISS

Monday, August 19, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Acquisition further strengthens technical advisory services in US

NEW YORK, Aug. 19, 2019 /PRNewswire/ -- Cello Health has announced further expansion in the

United States with the acquisition of New Jersey-based company Innovative Science Solutions, LLC ('ISS') on August 15.

ISS is a leading scientific consulting firm founded by Steven Weisman, PhD and David Schwartz, PhD nearly 20 years ago. The company specializes in strategic regulatory support for the healthcare industry and scientific support on health-related issues for legal counsel.

The technical service offering includes consultancy at all stages in the regulatory process, support of FDA Advisory Committee meetings, and data provision in legal defense of patent and intellectual property issues. Clients are predominantly US based, though the company also supports ex-US based clients with relevant needs in the US market.

Stephen Highley, Chairman of Cello Health, commented: "We are very pleased to welcome ISS to Cello Health. Consistent with Cello Health, ISS has achieved a strong reputation for provision of its scientific consulting services, and the specificity of these technical services is a perfect addition to Cello's focus on supporting client's along the most critical drug development and successful commercialization pathways."

"The acquisition of ISS is an excellent strategic fit as we continue our expansion in the US," added Julia Ralston, CEO, Cello Health US. "We are excited about how the clear synergies between this new offer and our existing capabilities will benefit Cello Health's clients and our work tackling their biggest challenges in navigating scientific, commercial, and regulatory approaches that increase an asset's market potential."

About Cello Health

Navigating Complexity > Steering Decisions > Building Solutions

Cello Health is a thought-leading health advisory firm, with experts in science, insight, strategy and communications. We are able to respond to our client's most complex challenges through a fusion of this expertise or as a specialist service within the capabilities of:

  • Business Insights and Analytics
  • Strategic and Scientific Consultancy
  • Scientific and Creative Communications

In the pursuit of better, Cello Health therefore builds bold solutions and makes insightful recommendations to help clients deliver medicines and innovations that have a remarkable impact on people's lives.

For further media information, please visit www.cellohealth.com

 

Cision View original content:http://www.prnewswire.com/news-releases/cello-health-acquires-iss-300903030.html

SOURCE Cello Health



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store